| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992927 | Journal of Thoracic Oncology | 2006 | 6 Pages |
Abstract
Women in ECOG 1594 had a 1.9-month statistically significant improvement in median survival compared with men, despite similar response rates and greater toxicity and no difference in other known prognostic factors. These data strongly support the significance of sex as a separate prognostic factor in advanced NSCLC and emphasize the importance of sex as a stratification factor in future phase III NSCLC trials.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Heather A. MD, Wei PhD, Joan H. MD, Corey J. MD, Alan B. MD, Chandra P. MD, David H. MD, for the Eastern Cooperative Oncology Group for the Eastern Cooperative Oncology Group,